Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

Head and Neck PET/CT: Therapy Response Interpretation Criteria (Hopkins Criteria)-Interreader Reliability, Accuracy, and Survival Outcomes.

Marcus C, Ciarallo A, Tahari AK, Mena E, Koch W, Wahl RL, Kiess AP, Kang H, Subramaniam RM.

J Nucl Med. 2014 Jun 19. pii: jnumed.113.136796. [Epub ahead of print]

PMID:
24947059
[PubMed - as supplied by publisher]
2.

Liver Standardized Uptake Value Corrected for Lean Body Mass at FDG PET/CT: Effect of FDG Uptake Time.

Chirindel A, Alluri KC, Tahari AK, Chaudhry M, Wahl RL, Lodge MA, Subramaniam RM.

Clin Nucl Med. 2014 May 28. [Epub ahead of print]

PMID:
24873794
[PubMed - as supplied by publisher]
3.

PET/CT in the management of thyroid cancers.

Marcus C, Whitworth PW, Surasi DS, Pai SI, Subramaniam RM.

AJR Am J Roentgenol. 2014 Jun;202(6):1316-29. doi: 10.2214/AJR.13.11673.

PMID:
24848831
[PubMed - in process]
4.

Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients.

Antoniou AJ, Marcus C, Tahari AK, Wahl RL, Subramaniam RM.

J Nucl Med. 2014 Apr 28;55(7):1062-1068. [Epub ahead of print]

PMID:
24777290
[PubMed - as supplied by publisher]
5.

FDG PET metabolic tumor volume segmentation and pathologic volume of primary human solid tumors.

Sridhar P, Mercier G, Tan J, Truong MT, Daly B, Subramaniam RM.

AJR Am J Roentgenol. 2014 May;202(5):1114-9. doi: 10.2214/AJR.13.11456.

PMID:
24758668
[PubMed - indexed for MEDLINE]
6.

Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters.

Yu J, Cooley T, Truong MT, Mercier G, Subramaniam RM.

J Med Imaging Radiat Oncol. 2014 Feb;58(1):18-24. doi: 10.1111/1754-9485.12081. Epub 2013 Jun 3.

PMID:
24529051
[PubMed - in process]
7.

Interreader agreement and variability of FDG PET volumetric parameters in human solid tumors.

Paidpally V, Mercier G, Shah BA, Senthamizhchelvan S, Subramaniam RM.

AJR Am J Roentgenol. 2014 Feb;202(2):406-12. doi: 10.2214/AJR.13.10841.

PMID:
24450684
[PubMed - indexed for MEDLINE]
8.

PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: evolving clinical imaging paradigm.

Subramaniam RM, Alluri KC, Tahari AK, Aygun N, Quon H.

J Nucl Med. 2014 Mar;55(3):431-8. doi: 10.2967/jnumed.113.125542. Epub 2014 Jan 9. Review.

PMID:
24408893
[PubMed - indexed for MEDLINE]
9.

Radiology research and medical students.

Whitworth PW, Agarwal A, Colucci A, Sherry SJ, Subramaniam RM.

Acad Radiol. 2013 Dec;20(12):1506-10. doi: 10.1016/j.acra.2013.09.013. Review.

PMID:
24200476
[PubMed - indexed for MEDLINE]
10.

FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumors.

Tahari AK, Alluri KC, Quon H, Koch W, Wahl RL, Subramaniam RM.

Clin Nucl Med. 2014 Mar;39(3):225-31. doi: 10.1097/RLU.0000000000000255.

PMID:
24152652
[PubMed - in process]
11.

Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC: a retrospective analysis with follow-up for 12 years.

Paidpally V, Tahari AK, Lam S, Alluri K, Marur S, Koch W, Wahl RL, Subramaniam RM.

J Nucl Med. 2013 Dec;54(12):2039-45. doi: 10.2967/jnumed.113.121285. Epub 2013 Oct 7.

PMID:
24101687
[PubMed - indexed for MEDLINE]
12.

Impact of concurrent diagnostic level CT with PET/CT on the utilization of stand-alone CT and MRI in the management of head and neck cancer patients.

Subramaniam RM, Agarwal A, Colucci A, Ferraro R, Paidpally V, Mercier G.

Clin Nucl Med. 2013 Oct;38(10):790-4. doi: 10.1097/RLU.0b013e31829f8ca5.

PMID:
23917783
[PubMed - indexed for MEDLINE]
13.

FDG PET/CT in the management of primary pleural tumors and pleural metastases.

Kruse M, Sherry SJ, Paidpally V, Mercier G, Subramaniam RM.

AJR Am J Roentgenol. 2013 Aug;201(2):W215-26. doi: 10.2214/AJR.13.10572. Review.

PMID:
23883236
[PubMed - indexed for MEDLINE]
14.

The role of PET/CT in the management of cervical cancer.

Mirpour S, Mhlanga JC, Logeswaran P, Russo G, Mercier G, Subramaniam RM.

AJR Am J Roentgenol. 2013 Aug;201(2):W192-205. doi: 10.2214/AJR.12.9830. Review.

PMID:
23883234
[PubMed - indexed for MEDLINE]
15.

Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging.

Ahlawat S, Blakeley J, Montgomery E, Subramaniam RM, Belzberg A, Fayad LM.

Skeletal Radiol. 2013 Sep;42(9):1317-22. doi: 10.1007/s00256-013-1626-3. Epub 2013 May 7.

PMID:
23649401
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

PET/CT mediastinal and liver FDG uptake: effects of biological and procedural factors.

Malladi A, Viner M, Jackson T, Mercier G, Subramaniam RM.

J Med Imaging Radiat Oncol. 2013 Apr;57(2):169-75. doi: 10.1111/1754-9485.12015. Epub 2012 Dec 28.

PMID:
23551774
[PubMed - indexed for MEDLINE]
17.

Science to practice: Molecular targeting with SPECT/CT and MR imaging in oncology--integration of functional and structural imaging.

Subramaniam RM.

Radiology. 2013 Apr;267(1):1-3. doi: 10.1148/radiol.12122734. No abstract available.

PMID:
23525713
[PubMed - indexed for MEDLINE]
18.

Evolving role of FDG PET/CT in multiple myeloma imaging and management.

Agarwal A, Chirindel A, Shah BA, Subramaniam RM.

AJR Am J Roentgenol. 2013 Apr;200(4):884-90. doi: 10.2214/AJR.12.9653. Review.

PMID:
23521465
[PubMed - indexed for MEDLINE]
19.

FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma.

Paidpally V, Chirindel A, Lam S, Agrawal N, Quon H, Subramaniam RM.

Imaging Med. 2012 Dec;4(6):633-647.

PMID:
23482696
[PubMed]
Free PMC Article
20.

PET-based primary tumor volumetric parameters and survival of patients with non-small cell lung carcinoma.

Davison J, Mercier G, Russo G, Subramaniam RM.

AJR Am J Roentgenol. 2013 Mar;200(3):635-40. doi: 10.2214/AJR.12.9138.

PMID:
23436855
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk